Stefan Schreiber

169.2k citations
896 papers · 51.4k indexed · 23 hit papers · h-index 111

Impact in

  • Genetics top 0.01%
    • Inflammatory Bowel Disease
  • Immunology top 0.05%
    • Immunodeficiency and Autoimmune Disorders

Papers in

Stefan Schreiber

863 papers receiving 50.2k citations

Hit Papers

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies 2023 · 190 citations
190199320262004201550010001.5k

Peers

Stefan Schreiber
Comparison fields: 5 of 198
  • Genetics 26.5k
  • Immunology 13.6k
  • Epidemiology 18.3k
  • Gastroenterology 2.8k
  • Aging 611
Replace Ramnik J. Xavier with:
Ramnik J. Xavier United States
Gabriel Núñez United States
Aldons J. Lusis United States
Diane Mathis United States
Dan R. Littman United States
Cisca Wijmenga Netherlands
Séverine Vermeire Belgium
Warren Strober United States
Fergus Shanahan Ireland
Mihai G. Netea Netherlands
Stefan Schreiber relative to Ramnik J. Xavier United States Ramnik J. Xavier's profile →
Citations per field
00.5×1.5×2.5×
Ramnik J. Xavier · 1×
Citations per year

Countries citing papers authored by Stefan Schreiber

Since Specialization
Citations

This map shows the geographic impact of Stefan Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Schreiber more than expected).

Fields of papers citing papers by Stefan Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Schreiber. The network helps show where Stefan Schreiber may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefan Schreiber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefan Schreiber Line = papers co-authored together Stefan Schreiber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20243
3 20242
4 20244
5 20241
6 20233
7 20230
8 202333
9 20232
10 202210
11 202112
12 201917
13 201654
14 20151
15 2009422
16
Effects of natalizumab on gut healing in a phase 3 study of active Crohn's disease therapy (ENACT-1)
20049
17
Infliximab in steroid-resistant ulcerative colitis – a randomised controlled trial.
200310
18 200182
19 199713
20 19968

About Stefan Schreiber

Stefan Schreiber is a scholar working on Genetics, Gastroenterology, Immunology, Epidemiology and Aging, having authored 896 papers that have together received 51.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (480 papers), Microscopic Colitis (265 papers), Eosinophilic Esophagitis (90 papers), Helicobacter pylori-related gastroenterology studies (84 papers), Immunodeficiency and Autoimmune Disorders (78 papers), Biosimilars and Bioanalytical Methods (43 papers), Autoimmune and Inflammatory Disorders Research (42 papers) and Gut microbiota and health (40 papers). The work is most often cited by research in Genetics (26.5k citations), Immunology (13.6k citations), Epidemiology (18.3k citations), Gastroenterology (2.8k citations) and Aging (611 citations). Stefan Schreiber has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Susanna Nikolaus, Paul Rutgeerts, Jochen Hampe, William J. Sandborn, Philip Rosenstiel, Brian G. Feagan, Jean‐Frédéric Colombel, Stephen B. Hanauer, Gary R. Lichtenstein and S. Ott. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Inflammatory Bowel Diseases and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026